Taro Pharmaceutical Industries Ltd banner

Taro Pharmaceutical Industries Ltd
F:TAL

Watchlist Manager
Taro Pharmaceutical Industries Ltd Logo
Taro Pharmaceutical Industries Ltd
F:TAL
Watchlist
Price: 40 EUR 1.01%
Market Cap: €1.5B

Profitability Summary

Taro Pharmaceutical Industries Ltd's profitability score is 44/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

44 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

44 / 100
Profitability
Score
44 / 100
Profitability
Score

Margins

Earnings Waterfall
Taro Pharmaceutical Industries Ltd

Margins Comparison
Taro Pharmaceutical Industries Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IL
Taro Pharmaceutical Industries Ltd
F:TAL
1.5B EUR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
829.8B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
579B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296B USD
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
221.8B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.6B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
117.8B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Taro Pharmaceutical Industries Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
Taro Pharmaceutical Industries Ltd
F:TAL
1.5B EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
829.8B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
579B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
221.8B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.6B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
117.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Taro Pharmaceutical Industries Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett